LAMP2 and hepatocellular carcinoma: High expression of LAMP2 has been reported to promote tumor development in multiple human cancers, including esophageal squamous cell carcinoma and hepatocellular carcinoma.[38–41] Our data from GEPIA2 database showed that LAMP2 were found significantly overexpressed in LGG, and high LAMP2 expression was significantly associated with poor overall survival in LGG patients.